FDA Approval Activities for this Drug… Maxalt (rizatriptan benzoate) Tablets & Maxalt-MLT (orally disintegrating tablet), 5 and 10 mg, Merck NDA 20-864/S8 & 20-865/S9 4/22/02 5/2/02 Maxalt (rizatriptan benzoate) Tablets & Maxalt-MLT (orally disintegrating tablet), 5 and 10 mg, Merck NDA 20-864 & 20-865 6/29/98 6/30/98 6/30/98 4/8/99 Maxalt Indication: Migraine Maxalt (rizatriptan)5 and 10 mg, . Merck & Co., NDA 20-865/S-001 NDA 20-864/S-003 Back to this API's Main Page.

Browse other API's patent/exclusivity pages… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Find API by Brand Name | Industry Information | Prescription Drug Websites | Search | Site Map         © 2009 Betterchem.com